Craft

Advanced
Stablix

Stablix

Total Funding

$63 M

Stablix Summary

Company Summary

Overview
Stablix Therapeutics is a biotechnology company that specializes in the field of targeted protein stabilization (TPS). It helps in bringing medicines to patients with unmet medical needs through establishing a small-molecule modality.
Type
Private
Status
Active
Founded
2021
HQ
New York, NY, US | view all locations
Website
https://www.stablix.com/
Cybersecurity rating
Sectors

Table of Contents

Key People

  • Carlo Rizzuto

    Carlo Rizzuto, Interim Chief Executive Officer

    • Ali Behbahani

      Ali Behbahani, Director

      • Kevin Sprott

        Kevin Sprott, Director, Senior Vice President of Drug Discovery, Co-Founder

        • Brian Bowman

          Brian Bowman, VP of In Vitro Pharmacology, Co-Founder

          LocationsView all

          1 location detected

          • New York, NY HQ

            United States

            3960 Broadway 6th floor

          Competitors and Similar Companies

          Compare competitors

          Footer menu

          Product

          Solutions

          Resources

          Company

          © Craft.co 2026
          Share price data provided by IEX